FDA Approved: FENOFIBRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves a supplemental application for fenofibrate by Mylan Pharmaceuticals, confirming continued access to this generic triglyceride-lowering therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hyperlipidemia
• Hypertriglyceridemia

Drugs mentioned

• FENOFIBRATE (Fenofibrate)

Snippet

SUPPL AP for FENOFIBRATE (FENOFIBRATE)